Charles River provides products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions accelerate their research and drug development efforts. We are focused on providing clients with ex… Read More »
Feel Better Now?
Ending one year, approaching the next
By Michael A. Martorelli
It’s always interesting to write a column about an event that is still in my future, but will have already happened by the time you read my words. Th… Read More »
Kendle will acquire the Phase II-IV Clinical Services business of Charles River Laboratories International, Inc. for approximately $215 million in cash. The move will strengthen Kendle's position in the clinical development industry, adding therapeut… Read More »